JANUVIA 100 MG Israel - English - Ministry of Health

januvia 100 mg

merck sharp & dohme (israel - 1996) company ltd, israel - sitagliptin as monohydrate phosphate - film coated tablets - sitagliptin as monohydrate phosphate 100 mg - sitagliptin - januvia is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes melitus.important limitations of use:januvia should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis as it would not be effective in these settings.januvia has not been studied in patients with a history of pancreatitis. it is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using januvia.

JANUVIA 25 MG Israel - English - Ministry of Health

januvia 25 mg

merck sharp & dohme (israel - 1996) company ltd, israel - sitagliptin as monohydrate phosphate - film coated tablets - sitagliptin as monohydrate phosphate 25 mg - sitagliptin - januvia is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes melitus.important limitations of use:januvia should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis as it would not be effective in these settings.januvia has not been studied in patients with a history of pancreatitis. it is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using januvia.

JANUVIA 25 MG Israel - English - Ministry of Health

januvia 25 mg

merck sharp & dohme (israel - 1996) company ltd, israel - sitagliptin as monohydrate phosphate - film coated tablets - sitagliptin as monohydrate phosphate 25 mg - sitagliptin - januvia is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes melitus.important limitations of use:januvia should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis as it would not be effective in these settings.januvia has not been studied in patients with a history of pancreatitis. it is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using januvia.

JANUVIA 25 MG Israel - English - Ministry of Health

januvia 25 mg

merck sharp & dohme (israel - 1996) company ltd, israel - sitagliptin as monohydrate phosphate - film coated tablets - sitagliptin as monohydrate phosphate 25 mg - sitagliptin - januvia is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes melitus.important limitations of use:januvia should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis as it would not be effective in these settings.januvia has not been studied in patients with a history of pancreatitis. it is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using januvia.

JANUVIA 25 MG Israel - English - Ministry of Health

januvia 25 mg

merck sharp & dohme (israel - 1996) company ltd, israel - sitagliptin as monohydrate phosphate - film coated tablets - sitagliptin as monohydrate phosphate 25 mg - sitagliptin - januvia is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes melitus.important limitations of use:januvia should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis as it would not be effective in these settings.januvia has not been studied in patients with a history of pancreatitis. it is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using januvia.

JANUVIA 25 MG Israel - English - Ministry of Health

januvia 25 mg

merck sharp & dohme (israel - 1996) company ltd, israel - sitagliptin as monohydrate phosphate - film coated tablets - sitagliptin as monohydrate phosphate 25 mg - sitagliptin - januvia is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes melitus.important limitations of use:januvia should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis as it would not be effective in these settings.januvia has not been studied in patients with a history of pancreatitis. it is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using januvia.

JANUVIA 50 MG Israel - English - Ministry of Health

januvia 50 mg

merck sharp & dohme (israel - 1996) company ltd, israel - sitagliptin as monohydrate phosphate - film coated tablets - sitagliptin as monohydrate phosphate 50 mg - sitagliptin - januvia is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes melitus.important limitations of use:januvia should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis as it would not be effective in these settings.januvia has not been studied in patients with a history of pancreatitis. it is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using januvia.

JANUVIA 50 MG Israel - English - Ministry of Health

januvia 50 mg

merck sharp & dohme (israel - 1996) company ltd, israel - sitagliptin as monohydrate phosphate - film coated tablets - sitagliptin as monohydrate phosphate 50 mg - sitagliptin - januvia is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes melitus.important limitations of use:januvia should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis as it would not be effective in these settings.januvia has not been studied in patients with a history of pancreatitis. it is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using januvia.

JANUVIA 50 MG Israel - English - Ministry of Health

januvia 50 mg

merck sharp & dohme (israel - 1996) company ltd, israel - sitagliptin as monohydrate phosphate - film coated tablets - sitagliptin as monohydrate phosphate 50 mg - sitagliptin - januvia is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes melitus.important limitations of use:januvia should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis as it would not be effective in these settings.januvia has not been studied in patients with a history of pancreatitis. it is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using januvia.

JANUVIA 50 MG Israel - English - Ministry of Health

januvia 50 mg

merck sharp & dohme (israel - 1996) company ltd, israel - sitagliptin as monohydrate phosphate - film coated tablets - sitagliptin as monohydrate phosphate 50 mg - sitagliptin - januvia is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes melitus.important limitations of use:januvia should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis as it would not be effective in these settings.januvia has not been studied in patients with a history of pancreatitis. it is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using januvia.